RARA CRAFT DATABASE for FDA Medical Devices
510(k)K201258

FDA DEVICE FACTS

EASYMAX Tag Self-Monitoring Blood Glucose System

Eps Bio Technology Corp.

FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。

DECISION DATESeptember 1, 2021PRODUCT CODENBW

Indications for use

A Intended Use(s): See Indications for Use below. B Indication(s) for Use: The system consists of the EASYMAX® Tag meter and the EASYMAX® Tag test strips. The EASYMAX® Tag meter only is used with the EASYMAX® Tag test strips to quantitatively measure glucose in fresh capillary whole blood from fingertip, palm, or forearm. The EASYMAX® Tag Self-Monitoring Blood Glucose System is intended for the quantitative measurement of glucose in fresh capillary whole blood samples drawn from the fingertip, palm, or forearm. Testing is done outside the body (In Vitro diagnostic use). It is indicated for use at home (over the counter [OTC]) by a single patient with diabetes and should not be shared, as an aid to monitor the effectiveness of diabetes control. The system is not to be used on neonates, nor for the diagnosis of, or screening for diabetes mellitus. Alternative site testing can be only used during steady-state blood glucose conditions. C Special Conditions for Use Statement(s):

- OTC - Over The Counter

- For in vitro diagnostic use

- The EASYMAX® Tag Self-Monitoring Blood Glucose System is intended to be used by a single patient and should not be shared.

- The system is not to be used on neonates, nor for the diagnosis of, or screening for EPS BIO TECHNOLOGY CORP. diabetes mellitus.

- Should not be used at altitude above 10,000 feet as there may be an inaccurate test results.

- A hematocrit (percentage of your blood that is red blood cells) that is either higher than 60% or lower than 20% can cause inaccurate results.

- Use of this device on multiple patients may cause the potential risk to transmission of Human Immunodeficiency Virus (HIV), Hepatitis C Virus (HCV), Hepatitis B Virus (HBV), or other bloodborne pathogens. D Special Instrument Requirements: EASYMAX® Tag Blood Glucose Meter

See the full product information製品情報をすべて見るには

Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。

Start free 7-day access7日間無料で利用するLog inログイン

OFFICIAL FDA SOURCES

FDA Record and Public Document Status

Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。

Information reviewed:情報の確認日: August 23, 2026